Legal Cannabis—a Bird’s Eye View on the Regulatory Scenario Based on Countries

The prevalence and acceptance of Cannabidiol (CBD) have encouraged forward-looking companies to shift their attention toward cannabis-based products. The legalization of cannabis for medical purposes will spur market growth. The Thailand government reportedly decriminalized the cultivation, distribution, consumption and marketing of all parts of the cannabis plant by June 2022. A robust regulatory framework will augur innovation and development for incumbent players. Notably, the legalization of cannabis in dozens of U.S. states and Canada has marked a new era in the governments’ approaches to cannabis. 

An in-depth assessment of the regulatory framework from Grand View Research will emphasize cannabis consumption & adoption, trade opportunities, market entry strategies and competitive scenarios of more than 15 countries. The final report, along with the database, will deep-dive on the following industry dynamics:

• Legalization scenario across the U.S. and Europe, ease of doing business and import-export scenario.
• Reintroduction of the MORE Act (Marijuana Opportunity, Reinvestment, and Expungement) in the U.S.
• Insights on clinical trials and studies. 
• Market penetration of established and emerging countries.
• Industry Developments across major regions. 

Get your copy or request for a free sample of the report “Legal Cannabis Regulatory Scenario,” compiled and published by Grand View Research

Legal Cannabis Regulatory Scenario Report Scope